A phase I placebo-controlled single and multiple ascending dose study investigating safety, tolerability, pharmacokinetics and pharmacodynamics of Entospletinib in healthy volunteers
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Entospletinib (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 21 Nov 2016 New trial record
- 26 Oct 2016 Results published in the Clinical Drug Investigation